Icentia receives authorization from Health Canada to distribute the CardioStatTM in the context of its experimental study

Icentia has obtained authorization under the Medical Devices Regulations of Canada for the sale of the CardioStat in the context of the experimental study it is conducting with the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ).

Icentia and IUCPQ are collaborating in this study to evaluate the performance of the CardioStat electrocardiography monitor and its efficacy at detecting most common types of atrial arrhythmias. Icentia plans to enrol the first patient of this multicenter, 300-patient study early this summer.